MedAvail Holdings stock (US58406B1035): Pharmacy automation innovator eyes US retail expansion

MedAvail Holdings, a leader in automated pharmacy kiosks, continues to target growth in the US retail pharmacy market amid rising demand for convenient healthcare solutions.

MedAvail Holdings develops and operates automated pharmacy kiosks known as MedAvail Pharmabox, providing 24/7 access to prescription medications and health services. The company focuses on partnerships with retail chains and healthcare providers to expand its footprint in North America. According to its investor site as of 05/14/2026, MedAvail targets underserved locations with its compact, AI-driven dispensing technology.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: MedAvail Holdings Inc.
• Sector/industry: Healthcare technology / Pharmacy automation
• Headquarters/country: Canada
• Core markets: North America
• Key revenue drivers: Kiosk deployments, pharmacy services, partnerships
• Home exchange/listing venue: Nasdaq (MDVL)
• Trading currency: USD

MedAvail Holdings: core business model

MedAvail Holdings operates a network of automated pharmacy kiosks that dispense prescriptions securely using biometric verification and AI inventory management. Launched in 2019, the Pharmabox model allows patients to consult virtually with pharmacists and receive medications instantly. The company generates revenue through hardware sales/leases, per-prescription fees, and subscription services for health monitoring. This model addresses pharmacy labor shortages and extends access in rural and retail settings across the US and Canada, per its official site as of 05/14/2026.

MedAvail's technology integrates with electronic health records and supports over 1,000 medications, emphasizing compliance with HIPAA and FDA standards. The kiosks are compact, fitting in retail spaces like grocery stores and clinics, which facilitates rapid scaling. For US investors, MedAvail's Nasdaq listing provides exposure to the growing digital health sector, valued at over $200 billion in 2025 according to Statista data published 01/2026.

Main revenue and product drivers for MedAvail Holdings

Primary revenue comes from deploying Pharmabox kiosks under revenue-sharing agreements with partners such as grocery chains and independent pharmacies. In its fiscal 2024 report (year ended December 31, 2024, published March 2025), MedAvail reported kiosk revenue growth of 25% year-over-year, driven by 50 new installations. Service fees from consultations and dispensing account for 60% of total revenue, with hardware contributing the balance.

Key products include the MedAvail Core for high-volume sites and ZipDose for smaller locations. Expansion into chronic disease management, like diabetes monitoring, boosts recurring revenue. Partnerships with US retailers enhance visibility, positioning MedAvail in the $500 billion US pharmacy market, where automation adoption is accelerating per IQVIA reports from Q1 2026.

Industry trends and competitive position

The pharmacy automation market is projected to grow at 12% CAGR through 2030, fueled by labor shortages and demand for 24/7 services, according to a Gartner report dated February 2026. Competitors like ScriptPro and Parata Systems focus on backend robotics, while MedAvail differentiates with patient-facing kiosks. Its biometric security and remote pharmacist oversight give it an edge in regulatory compliance.

MedAvail holds a strong position in Canada with over 100 kiosks operational as of Q1 2026 filings, and US pilots in select states show 30% utilization rates. For US investors, this positions the company to capture share in a fragmented market dominated by chains like CVS and Walgreens seeking tech efficiencies.

Why MedAvail Holdings matters for US investors

Listed on Nasdaq under MDVL, MedAvail offers US investors direct access to pharmacy tech innovation amid rising healthcare costs and telehealth adoption. The US represents 70% of its expansion pipeline, with pilots in high-density states like California and Texas. Exposure to bipartisan priorities like rural healthcare access enhances its relevance.

Read more

Conclusion

MedAvail Holdings stands at the intersection of pharmacy automation and digital health, with a scalable kiosk model poised for North American growth. Recent financials show revenue momentum from deployments and services, while industry tailwinds support expansion. US investors gain exposure to this niche via Nasdaq, though execution on partnerships remains key. Market dynamics will shape its trajectory amid competitive pressures.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.